Zhejiang NHU's revenue decline continues in Q3; Hebang Biotech sees growth in Q3 revenue from nutrients

Summary: For Q3 2023, Zhejiang NHU's revenue went down by 2.74% YoY and down by 5.59% QoQ; Hebang Biotech's revenue from its "nutrients, intermediates and by-products" category (mainly including liquid MHA-FA) grew by 58.80% QoQ.On 26 Oct., Zhejiang ...

Amino Acids China E-News 202310

www.cnchemicals.com